6. Lahey FH, Ackerson EB. Retroperitoneal
cysts. Ann Surg. 1934;100:231-237.
7. Fletcher C, Unni KK, Mertens F. WHO
Classification of Soft Tissue Tumors. In: Fletcher C, Unni
KK, Mertens F, editors. Pathology and Genetics: Tumors of
Soft Tissue and Bone. World Health Organization
Classification of Tumors. International Agency for Research
on Cancer Press; 2002. p. 9-12.
8. Greene FL, Page DL, Fleming FD, Fritz A,
Balch CM, Haller DG, Morrow M, editores. American Joint
Committee on Cancer: Cancer Staging Manual. 6.a ed. New York:
Springer; 2002. p. 221-6.
9. Spencer Liles J, Ching Wei D Tzeng, Joshua J
Short, Kulesza P, Heslin MJ. Retroperitoneal and
Intraabdominal Sarcoma. Curr Probl Surg.
2009;46:445-503.
10. De Schepper AM, Bloem JL. Soft Tissue
Tumors. Grading, Staging and Tissue – Specific Diagnosis. Top
Magn Reson Imaging. 2007; 18: 431-444.
11. Hueman MT, Ahuja N. Soft tissue sarcoma,
Surg Clin N Am. 2008; 88: 451-680.
12. Voros D, Theodorou D, Ventouri K,
Prachalias A, Danias N, Gouliamos A. Retroperitoneal Tumors:
Do the satellite Tumors Mean Something? Journal of Surgical
Oncology, 1998; 68: 30 – 33.
13. Fletcher C, The evolving classification of
soft tissue tumors: an update based on the new WHO
classification. Histopatology. 2006; 48:
3-12.
14. Fadul D, Fayad LM. Advanced modalities for
the imaging of sarcoma. Surg Clin N Am. 2008; 88:
521-537.
15. Verdugo MA. Ultrasonido en el estudio de
tumores de partes blandas. Rev Chil Radiol. 2009;15:
5-18.
16. Cogbill TH, Jarman BT. Diagnostic Imaging
for General Surgeon. Surg Clin N Am. 2011; 91:
1-276.
17. Nishino M, Hayakawa K, Minami M, Yamamoto
A, Ueda H, Takasu K. Primary retroperitoneal neoplasms: CT
and MR imaging findings with anatomic and pathologic
diagnostic clues. RadioGraphics 2003; 23: 45-57.
18. Francis IR, Cohan RH, Varma DG, Sondak VK.
Retroperitoneal sarcomas. Cancer Imaging .2005; 5: 89 –
94.
19. Kilkenny JW III, Bland KI, Copeland EM III:
Retroperitoneal sarcoma: The University of Florida
experience. J Am Coll Surg. 1996; 182: 329-339.
20. Van Rijswijk CSP, Kunz P, Hogendoorn PCW,
Taminiau AHM, Doornbos J, Bloem JL. Diffusion-Weighted MRI in
the Characterization of Soft-Tissue Tumors. J Magn Reson
Imaging. 2002; 15: 302-307.
21. Schnapauff D, Zeile M, Ben Niederhagen M,
Fleige B, Tunn Per-Ulf, Hamm B, Dudeck O. Diffusion-Weighted
Echo-Planar Magnetic Resonance Imaging for the Assessment of
Tumor Cellularity in Patients With Soft-Tissue Sarcomas.
Journal of Magnetic Resonance Imaging. 2009; 29:
1355-59.
22. Coindre JM. Immunohistochemistry in the
diagnosis of soft tissue tumous. Histopathology. 2003; 43:
1-16.
23. Ordoñez JL, Osuna D,
Garcia-Dominguez DJ, Amaral AT, Otero-Motta AP, Mackintosch
C, et al. The clinical relevance of molecular genetics in
soft tissue sarcomas. Adv Anat Pathol. 2010; 17:
162-181.
24. Álava E de. Patologia Molecular de
los Sarcomas. Oncologia. 2005; 28: 426 – 442.
25. Tolcher AW, Sarantopoulos J, Patnaik A,
Phase I, pharmacokinetic and pharmacodynamic study of AMG
479, a fully human monoclonal antibody to insulin-like growth
factor receptor 1. J Clin Oncol. 2009; 27:
5800-5807
26. Ambrosini G, Cheema HS, Seelman S,
Sorafenib inhibits growth and mitogen-activated protein
kinase signaling in malignant peripheral nerve sheath cells.
Mol Cancer Ther. 2008;7:890-896.
27. Maki RG, D`Adamo DR, Keohan ML, Phase II
study of sorafenib in patients with metastatic or recurrent
sarcomas. J Clin Oncol. 2009;27:3133-3140.
28. Hensley ML, Sill MW, Scribner DR Jr,
Sunitinib malate in the treatment of recurrent or persistent
uterine leiomyosarcoma: a Gynecologic Oncology Group phase II
study. Gynecol Oncol. 2009; 115: 460-465.
29. George S, Merriam P, Maki RG, Multicenter
phase II trial of sunitinib in the treatment of
nongastrointestinal stromal tumor sarcomas. J Clin Oncol.
2009;27:3154-3160.
30. Yuan R, Kay A, Berg WJ, Targeting
tumorigenesis: development and use of mTOR inhibitors in
cancer therapy. J Hematol Oncol. 2009;2:45.
31. Ordonez JL, Martins AS, Osuna D, Targeting
sarcomas: therapeutic targets and their rational. Semin Diagn
Pathol. 2008;25:304-316.
32. Muller CR, Paulsen EB, Noordhuis P,
Potential for treatment of liposarcomas with the MDM2
antagonist Nutlin-3A. Int J Cancer.
2007;121:199-205.
33. Raut Ch, Pisters P, Retroperitoneal
Sarcomas: Combined – Modality Treatment Approaches. J Surg
Oncol. 2006; 94 : 81 – 87.
34. Hueman MT, Herman JM, Ahuja N. Management
of Retroperitoneal Sarcomas. Surg Clin N Am. 2008; 88:
583-597.
35. Lewis JJ, Leung D, Woodruff JM, Brennan MF.
Retroperitoneal Soft – Tissue Sarcoma. Analysis of 500
Patients Treated and Followed at a Single Institution. Ann
Surg. 1998;228:355-365.
36. Grimer R, Judson I, Peake D, Seddon B.
Guidelines for the management of soft tissue sarcomas.
Sarcomas. 2010; 15: 1-15.
37. Stojadinovic A, Leung DHY, Hoss A, Jaques
DP, Lewis JJ, Brennan MF, Analisis of the prognostic
significance of microscopic margins in 2084 localized primary
adult soft tissue sarcomas. Ann Surg. 2002; 235:
424-434.
38. Stoeckle E, Coindre JM, Bonvalot S, et al.
Prognostic factors in retroperitoneal
sarcoma: a multivariate analysis of a series of 165
patients of the French Cancer Center Federation Sarcoma Group.
Cancer. 2001;92:359-68.
39. Ferrario T, Karakousis CP. Retroperitoneal
Sarcomas. Arch Surg. 2003; 38:248-251.40. Dalton RR, Donohue JH, Mucha P Jr, van
Heerden JA, Reiman HM, Chen SP. Management of retroperitoneal
sarcomas. Surgery. 1989; 4: 725-732.41. Catton Ch N, O`Sullivan B, Kotwall C,
Cummings B, Hao Y, Fornasier V. Outcomes and prognosis in
retroperitoneal soft tissue sarcoma. International Journal of
Radiation Oncology. 1994; 29: 1005-1010.42. Singer S, Corson JM, Demetri GD, Healey
EA, Marcus K, Eberlein TJ. Prognostic factors predictive of
survival for truncal and retroperitoneal soft-tissue sarcoma.
Ann Surg. 1995;221:185-95.43. Van Doom RC, Gallee MP, Hart AA, Gortzak E,
Rutgers EJ, van Coevorden F, Keus RB, Zoetmulder FA.
Resecable retroperitoneal sof tissue sarcomas. The effect of
extent of resection and postoperative radiation therapy on
local tumor control. Cancer. 1994;73: 637-642.44. Storm FK, Eilber FR, Mirra J, Morton DL.
Retroperitoneal sarcomas: a reappraisal of treatment. Journal
of Surgical Oncology. 1981; 17: 1-7.45. Jaques DP, Coit DG, Hajdu SI, Brennan MF,
Management of Primary and Recurrent Soft tissue Sarcoma of
the Retroperitoneum. Ann Surg. 1990; 212:
51-59.46. Malerba M, Battista G, Pacelli F, Carriero
C, Caprino P, Piccioni E, Crucitti P, Crucitti F. Primary
Retroperitoneal Soft Tissue Sarcomas: Results of aggressive
surgical treatment. World J Surg 1993; 23:
670-675.47. Karakousis CP, Kontzoglu K, Driscoll DL.
Resecability of retroperitoneal sarcomas: a matter of
surgical technique? Eur J Surg Oncol. 1995; 21:
617-622.48. Mc Grath PC. Retroperitoneal sarcomas.
Semin Surg Oncol. 1994;10:364-8.49. Shibata D, Lewis JJ, Leung DH, Brennan MF.
Is there a role for incomplete resection in the management of
retroperitoneal liposarcomas? JAm Coll Surg.
2001;193:373-9.50. Strauss DC, Hayes AJ, Thway K, Moskovic EC,
Fisher C, Thomas JM. Surgical management of primary
retroperitoneal sarcoma. British Journal of Surgery 2010; 97:
698 – 706.51. Marin Gomez LM, Vega Ruiz V, Garcia
Ureña MA. Sarcomas Retroperitoneales. Aportacion de
cinco nuevos casos y revisión de la situación
actual. Cir Esp. 2007; 82:172-176.52. Anaya DA, Lev DC, Pollock RE, The role of
surgical margin status in retroperitoneal sarcoma. J Surg
Oncol. 2008;98:607-610.53. Gronchi A, Casali PG, Fiore M, Mariani L,
Lo Vullo S, Bertulli R, et al. Retroperitoneal Soft Tissue
Sarcomas. Patterns of Recurrence in 167 Patients Treated at a
Single Institution. Cancer. 2004; 100: 2448 –
2455.54. Bonvalot S, Rivoire M, Castaing M, Stoeckle
E, Le Cesne A, Blay JY, Laplanche A. Primary retroperitoneal
sarcomas: a multivariate analysis of surgical factors
associated with local control. J Clin Oncol. 2009; 27:
31.37.55. Virseda Rodriguez JA, Donate Moreno MJ,
Pasto Navarro H, Carrion Lopez P, Martinez Ruiz J, Martinez
Sanchiz C, Peran Teruel M. Tumores Retroperitoneales
Primarios. Revisión de nuestros casos de los
últimos diez años. Arch Esp Urol.
2010;63:13-22.56. Gronchi A, Lo Vullo S, Fiore M, Musi Ch,
Stacchiotti S, Collini P, et al. Aggressive surgical policies
in a retrospectively reviewed single-institution case series
of retroperitoneal soft tissue sarcoma patients. J Clin
Oncol. 2009;27:24-30.57. Schwarzbach MHM, Hormann Y, Hinz U,
Leowardi Ch, Bückler D, Mechtersheimer G, et al.
Clinical results of surgery for retroperitoneal sarcoma with
major blood vessel involvement. J Vasc Surg.
2006;44:46-55.58. Medina-Villaseñor EA,
Martinez-Macias R, Diaz-Rodriguez L, Barra-Martinez R, de la
Garza-Navarro JM, Quezada-Adame I, Neyra-Ortiz E. Sarcomas
retroperitoneales. Cir Gen 2006;28:77-82.59. Fong Y, Coit DG, Woodruff JM, Brennan MF.
Lymph node metastasis from soft tissue sarcoma in adults.
Analysis of data from a prospective database of 1772 sarcoma
patients. Ann Surg. 1993; 217: 72-7.60. Van Geel AN, Pastorino U, Jauch KW, Judson
IR, van Coevorden F, Buesa JM, et al. Surgical treatment of
lung metastases: The European Organization for Research and
Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study
of 255 patients. Cancer 1996; 77: 675-682.61. Sindelar WF, Kinsella TJ, Chen
PW, DeLaney TF, Tepper JE, Rosenberg SA, et al.
Intraoperative radiotherapy in
retroperitoneal sarcomas. Final results of a
prospective,
randomized, clinical trial. Arch Surg
1993;128:402-410.
62. Pawlik TM, Pisters PWT, Mikula L, Feig BW,
Hunt KK, Cormier JN, et al. Long-term results of two
prospective trials of preoperative external beam radiotherapy
for localized intermediate- or high-grade retroperitoneal
soft tissue sarcoma. Ann Surg Oncol.
2006;13:508-17.63. Pisters PW, O"Sullivan B. Retroperitoneal
sarcomas: combined modality treatment approaches. Curr Opin
Oncol. 2002;14:400-5.64. Jones JJ, Catton CN, O`Sullivan B, Couture
J, Heisler RL, Kandel RA, et al. Initial results of a trial
of preoperative external-beam radiation therapy and
postoperative brachytherapy for retroperitoneal sarcoma. Ann
Surg Oncol 2002;9:346-354.65. Petersen IA, Haddock MG, Donohue JH,
Nagorney DM, Grill JP, Sargent DJ, et al. Use of
intraoperative electron beam radiotherapy in the management
of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol
Biol Phys 2002; 52:469-475.66. Gieschen HL, Spiro IJ, Suit HD, Ott MJ,
Rattner DW, Aucukiewicz ,et al. Long-term results of
intraoperative electron beam radiotherapy for primary and
recurrent retroperitoneal soft tissue sarcoma. Int J Radiat
Oncol Biol Phys 2001;50:127-131.67. Tzeng CW, Fiveash JB, Popple RA, Arnoletti
JP, Russo SM, Urist MM et al. Preoperative radiation therapy
with selective dose escalation to the margin at risk for
retroperitoneal sarcoma. Cancer 2006;107:371-379.68. White JS, Biberdorf D, Difrancesco LM,
Kurien E, Temple W. Use of tissue expanders and preoperative
external beam radiotherapy in the treatment of
retroperitoneal sarcoma. Ann Surg Oncol
2007;14:583-590.69. Zlotecki RA, Katz TS, Morris CG, Lind DS,
Hochwald SN. Adjuvant radiation therapy for resecable
retroperitoneal soft tissue sarcoma: the University of
Florida experience. Am J Clin Oncol
2005;28:310-316.70. Heslin MJ, Lewis JJ, Nadler E, Newman E,
Woodruff JM, Casper ES, et al. Prognostic factors associated
with long-term survival for retroperitoneal sarcoma:
implications for management. J Clin Oncol.
1997;15:2832-9.71. Gilbeau L, Kantor G, Stoeckle E, Lagarde P,
Thomas L, Kind M, et al. Surgical resection and radiotherapy
for primary retroperitoneal sof tissue sarcoma. Radiotherapy
and Oncology. 2002 ;65 :137-143.72. Kaushal A, Citrin D. The Role of Radiation
Therapy in the Management of Sarcomas. Surg Clin N Am. 2008;
88: 629 – 646.73. Thornton K. Chemoterapeutic management of
soft tissue sarcoma. Surg Clin N Am. 2008;88:
647-660.74. Hensley ML, Maki R, Venkatraman E, Geller
G, Lovegren M, Aghajanian C, et al. Gemcitabine and docetaxel
in patients with unresectable lieomyosarcoma: results of a
phase II trial. J Clin Oncol. 2002;20:2824-31.75. Maki RG. Gemcitabine and Docetaxel in
metastatic sarcoma: past, present and future. The Oncologist.
2007;12:999-1006.76. Stojadinovic A, Leung DHY, Hoss A, Jaques
DP, Lewis JJ, Brennan MF. Analisis of the prognostic
significance of microscopic margins in 2084 localized primary
adult soft tissue sarcomas. Ann Surg.
2002;235:424-434.77. van Dalen T, Hoekstra HJ, van Geel AN, van
Coevorden F. Dutch Soft Tissue Sarcoma Group. Locoregional
recurrence of retroperitoneal soft tissue sarcoma: second
chance of cure forselected patients. Eur J Surg
Oncol. 2001;27:564 -568.78. Hassan I, Park SZ, Donohue JH, Operative
Management of Primary Retroperitoneal Sarcomas. A Reappraisal
of an Institutional Experience. Ann Surg. 2004;
239:244-250.79. Bonvalot S, Vanel D, Terrier P, et al.
Traitement des récidives des sarcomes
retro-péritonéaux. Bull Cancer.
2004;91:845-852.80. van Dalen T, Hennipman A, Van Coevorden F,
Hoekstra HJ, van Geel BN, Slootweg P. Evaluation of a
clinically aplicable post-surgical classification system for
primary retroperitoneal sofa-tissue sarcoma. Ann Surg Oncol.
2004;11:485-90.81. Anaya DA, Lahat G, Wang X, Xiao L, Tuvin D,
Pisters PW, et al. Establishing prognosis in retroperitoneal
sarcoma: a new histology-based paradigm. Ann Surg Oncol.
2009;16:667-675.82. Bautista N, SuW, O"Connell TX.
Retroperitoneal soft-tissue sarcomas: prognosis and treatment
of primary and recurrent disease. Am Surg
2000;66:832-6.83. Chiappa A, Zbar AP, Biffi R, Bellomi M,
Orecchia R, Marsiglia H, et al. Primary and recurrent
retroperitoneal sarcoma: factors affecting survival and
long-term outcome. Hepatogastroenterology
2004;51:1304-1309.84. Erzen D, Sencar M, Novak J. Retroperitoneal
sarcoma: 25 years of experience with aggressive surgical
treatment at the Institute of Oncology, Ljubljana. J Surg
Oncol 2005;91:1-9.85. Pacelli F, Tortorelli AP, Rosa F, Papa V,
Bossola M, Sanchez AM, et al. Retroperitoneal soft tissue
sarcoma: prognostic factors and therapeutic approaches.
Tumori. 2008;94:497-504.86. Gholami S, Jacobs CD, Kapp DS,
Parast LM, Norton JA. The value of surgery for
retroperitoneal sarcoma. Sarcoma 2009;2009: 605840. Epub 2009
Oct 8.87. Lehnert T, Cardona S, Hinz U, Willeke, F,
Mechtersheimer G, Treiber M, et al. Primary and locally
recurrent retroperitoneal soft-tissue sarcoma: local control
and survival. Eur J Surg Oncol 2009;35:986-993.88. Grobmyer SR, Wilson JP, Apel B, Knapik J,
Copeland E, Bland K et al. Recurrent retroperitoneal sarcoma:
impact of biology and therapy on outcomes. J Am Coll Surg.
2010;210:602-610.89. Mendenhall WM, Zlotecki RA, Hochwald SN,
Hemming AW, Grobmyer SR, Cance WG. Retroperitoneal soft
tissue sarcoma. Cancer. 2005;104:669-75.90. Xu YH, Guo KJ, Guo RX, Ge CL, Tian YL, He
SG. Surgical management of 143 patients with adult primary
retroperitoneal tumor. World J Gastroenterol 2007; 13:
2619-2621.91. Windham TC, Pisters PWT. Retroperitoneal
sarcomas. Cancer Control. 2005;12:36-43.92. Potter DA, Glenn J, Kinsella T, et al.
Patterns of recurrence in patients with high-grade
soft-tissue sarcomas. J Clin Oncol. 1985;3:
353-66.93. Avancès Ch, Mottet N, Mahatmat A.
Prognostic factors for first recurrence in patients with
retroperitoneal sarcomas. Urologic Oncology: Seminars and
Original Investigations. 2006;24:94-96.94. Anaya D, Lahat G, Liu J, Xing Y, Cormier
JN, Pisters PW, et al. Multifocalidad in retroperitoneal
sarcoma. A prognostic factor critical to surgical
decisión-making. Ann Surg.
2009;249:137-142.95. Cheifetz R, Catton C, Kandel R, O"Sullivan
B, Couture J, Swallow C. Recent progress in the management of
retroperitoneal sarcoma. Sarcoma. 2001;5:17-26.96. Echenique-Elizondo M,
Amondarain-Arratíbel JA. Liposarcoma retroperitoneal
gigante. Cir Esp. 2005;77:293-5.
Anexos
Anexo 1. Clasificación OMS /
2002, tumores partes blandas.
Tejido adiposo
| ICD-O (726)* | ||
Lipoma | 8850/0 | ||
Lipomatosis | 8850/0 | ||
Lipomatosis del | 8850/0 | ||
Lipoblastoma-lipoblastomatosis | 8881/0 | ||
Angiolipoma | 8861/0 | ||
Myolipoma | 8890/0 | ||
Lipoma condroide | 8862/0 | ||
Angiomyolipoma extrarenal | 8860/0 | ||
Myelolipoma extra adrenal | 8870/0 | ||
Células fusiformes – | 8857/0 | ||
Hibernoma | 8880/0 | ||
| |||
Tumor lipomatoso atípico / | 8851/3 | ||
| |||
Liposarcoma | 8858/3 | ||
Liposarcoma mixoide | 8852/3 | ||
Liposarcoma células | 8853/3 | ||
Liposarcoma pleomorfico | 8854/3 | ||
Liposarcoma tipo mixto | 8855/3 | ||
Liposarcoma sin otra | 8850/3 | ||
Tumor fibroblastico –
| |||
Fascitis nodular | |||
Fascitis proliferativa | |||
Myositis proliferativa | |||
Myositis osificante | |||
Fascitis isquémica | |||
Elastofibroma | 8820/0 | ||
Hamartoma fibroso de la | |||
Myofibroma/myofibromatosis | 8824/0 | ||
Fibromatosis colli | |||
Fibromatosis hialina | |||
Fibromatosis de cuerpos de | |||
Fibroma vaina tendinosa | 8810/0 | ||
Fibroblastoma | 8810/0 | ||
Myofibroblastoma tipo | 8825/0 | ||
Fibroma calcificante | 8810/0 | ||
Angiomyofibroblastoma | 8826/0 | ||
Angiofibroma celular | 9160/0 | ||
Fibroma tipo nucal | 8810/0 | ||
Fibroma Gardner | 8810/0 | ||
Tumor fibroso calcificante | |||
Angiofibroma células | 9160/0 | ||
| |||
Fibromatosis superficial (plantar – | 8821/1 | ||
Fibromatosis tipo desmoide | |||
Lipofibromatosis | |||
| |||
Tumor fibroso solitario y | 8815/1 – 9150/1 | ||
Tumor myofibroblastico | 8825/1 | ||
Sarcoma myofibroblastico bajo | 8825/3 | ||
Sarcoma fibroblastico | 8811/3 | ||
Fibrosarcoma infantil | 8814/3 | ||
| |||
Fibrosarcoma del adulto | 8810/3 | ||
Mixofibrosarcoma | 8811/3 | ||
Sarcoma fibromixoide de bajo grado Tumor de células | 8811/3 | ||
Fibrosarcoma epitelioide | 8810/3 | ||
Tumor tipo Benigno | |||
Tumor de la vaina tendinosa de | 9252/0 | ||
Células gigantes tipo | 9251/0 | ||
Histocitoma fibroso profundo | 8830/0 | ||
Intermedio (raramente | |||
Tumor fibrohistocitico | 8835/1 | ||
Tumor células | 9251/1 | ||
Maligno | |||
Histocitoma fibroso maligno | 8830/3 | ||
Histocitoma fibroso maligno | 8830/3 | ||
Histocitoma fibroso maligno | 8830/3 | ||
Tumores musculo | |||
Angioleiomioma | 8894/0 | ||
Leiomioma profundo | 8890/0 | ||
Leiomioma genital | 8890/0 | ||
Leiomiosarcoma | 8890/3 | ||
Tumores Pericitico | |||
Tumor glomus Tumor glomus maligno | 8711/0 | ||
Miopericitoma | 8713/1 | ||
Tumores del musculo Benigno | |||
Rabdomioma Tipo adulto Tipo fetal Tipo genital | 8900/0 8904/0 8903/0 8905/0 | ||
Maligno | |||
Rabdomiosarcoma embrionario | 8910/3 8912/3 8910/3 | ||
Rabdomiosarcoma alveolar (solido, | 8920/3 | ||
Rabdomiosarcoma | 8901/3 | ||
Tumores vasculares | |||
Benigno | |||
Hemangiomas
| 9120/0 9131/0 9121/0 9123/0 9122/0 9132/0 9120/0 | ||
Hemangioma epitelioide | 9125/0 | ||
Angiomatosis | |||
Linfangioma | 9170/0 | ||
Intermedio (localmente | |||
hemangioendotelioma | 9130/1 | ||
Intermedio (raramente | |||
Hemangioendotelioma | 9135/1 | ||
Angioendotelioma papilar | 9135/1 | ||
Hemangioendotelioma | 9130/1 | ||
Sarcoma de Kaposi | 9140/3 | ||
Maligno | |||
Hemangioendotelioma | 9133/3 | ||
Angiosarcoma partes | 9120/3 | ||
Tumores condro- | |||
Condroma partes blandas | 9220/0 | ||
Condrosarcoma | 9240/3 | ||
Osteosarcoma | 9180/3 | ||
Tumores de diferenciación | |||
Benigno | |||
Mixoma intramuscular (incluye | 8840/0 | ||
Mixoma yuxta-articular | 8840/0 | ||
Angiomixoma profundo | 8841/0 | ||
Tumor angioestasico hialinizante | |||
Thimoma hamartomatoso | 8587/0 | ||
Intermedio (raramente | |||
Histocitoma fibroso | 8836/1 | ||
Tumor fibromixoide osificante | 8842/0 | ||
Tumor mixoide – mioepitelioma – | 8940/1 8982/1 9373/1 | ||
Maligno | |||
Sarcoma sinovial | 9040/3 | ||
Sarcoma epitelioide | 8804/3 | ||
Sarcoma partes blandas | 9581/3 | ||
Sarcoma partes blandas células | 9044/3 | ||
Condrosarcoma mixoide | 9231/3 | ||
PNET/Extraesqueletico Ewing tumor | 9364/3 9260/3 | ||
Tumor desmoplasico de células | 8806/3 | ||
Tumor rabdoide extrarenal | 8963/3 | ||
Mesenquimoma maligno | 8990/3 | ||
PEComa. Neoplasma con | |||
Sarcoma intimal | 8800/3 |
*Código de la clasificación
internacional de enfermedades oncológicas.
MONOGRAFIA DE ASISTENTE
DE CIRUGIA GENERAL
Autor:
Dr Pablo
Valsangiácomo
Clínica Quirúrgica 3. Prof Dr
Luis Ruso.
Hospital Maciel. Facultad de
Medicina.
Montevideo. Uruguay
Junio 2011
Página anterior | Volver al principio del trabajo | Página siguiente |